A unique collection of xnum DNA Damage & Repair related compounds for high throughput screening (HTS) and high content screening (HCS);

Well-chosen xnum compounds with unique structures targeting DNA damage & repair;

A unique collection of xnum compounds with anti-cancer activity for high throughput screening (HTS) and high content screening (HCS);

A unique collection of xnum compounds with anti-lung cancer therapeutic activity or targeting lung cancer’s major signaling pathways, can be used for anti-lung cancer drug discovery and mechanism study；

A unique collection of xnum compounds with known anti-cancer activity for high throughput screening (HTS) and high content screening (HCS);

A unique collection of xnum anti-virus compounds effective for new anti-virus drugs high throughput screening and high content screening;

Oxidative stress reflects an imbalance between the systemic manifestation of reactive oxygen species (ROS) and a biological system's ability to readily detoxify the reactive intermediates or repair the resulting damage. Disturbances in the normal redox state of cells can cause toxic effects through the production of peroxides and free radicals that damage all components of the cell, including proteins, lipids, and DNA. In humans, oxidative stress is thought to be involved in the development of atherosclerosis, heart failure, myocardial infarction, cancer, infection etc. Antioxidants are a class of compounds that counteract oxidative stress and reduce oxidative damage. The TargetMol Antioxidant Compound Library is a unique collection of xnum small molecules with inhibitory effects on oxidative stress and is a useful tool for high-throughput screening and high-content screening in the study of oxidative stress.

A unique collection of xnum compounds with anti-AD activities or acting on main drug targets of AD can be used for HTS and HCS.

A unique collection of xnum anti-aging compounds for high throughput screening (HTS) and high content screening (HCS);

A unique collection of xnum histone modification related compounds for high throughput screening (HTS) and high content screening (HCS);

A unique collection of xnum compounds with defined autophagy-inducing or -inhibitory activity for research in autophagy, high throughput screening (HTS) and high content screening (HCS) for new drugs;

A unique collection of 149 neuroregeneration related compounds for high throughput and high content screening;

A unique collection of xnum approved anti-cancer drugs for high throughput screening (HTS) and high content screening (HCS);

A unique collection of xnum anticancer drugs for high throughput screening (HTS) and high content screening (HCS);

A unique collection of xnum anti-cancer compounds for high throughput screening (HTS) and high content screening (HCS);

A unique collection of xnum ubiquitination related small chemicals can be used for high throughput and high content screening；

Well-chosen xnum anti-tumor compounds with unique structures;